Cargando…

N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study

BACKGROUND: Women with symptoms and signs of ischemia, preserved left ventricular ejection fraction (LVEF), and no obstructive coronary artery disease (CAD), often have coronary microvascular dysfunction (CMD), and are at risk of future heart failure with preserved ejection fraction (HFpEF). N-termi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Erika, Wei, Janet, Nelson, Michael D., Bakir, May, Mehta, Puja K., Shufelt, Chrisandra, Minissian, Margo, Sharif, Behzad, Pepine, Carl J., Handberg, Eileen, Cook-Wiens, Galen, Sopko, George, Bairey Merz, C. Noel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714343/ https://www.ncbi.nlm.nih.gov/pubmed/33270715 http://dx.doi.org/10.1371/journal.pone.0243213

Ejemplares similares

Coronary endothelial dysfunction appears to be a manifestation of a systemic process: A report from the Women’s Ischemia Syndrome Evaluation – Coronary Vascular Dysfunction (WISE-CVD) study
por: Jalnapurkar, Sawan, et al.
Publicado: (2021)

Autoimmune rheumatic diseases in women with coronary microvascular dysfunction: a report from the Women's Ischemia Syndrome Evaluation—Coronary Vascular Dysfunction (WISE-CVD) project
por: Chen, Melanie T., et al.
Publicado: (2023)

Cardiovascular and pregnancy outcomes in women with coronary microvascular dysfunction: a case series
por: Pacheco, Christine, et al.
Publicado: (2019)

Temporal Trends in Angina, Myocardial Perfusion, and Left Ventricular Remodeling in Women With No Obstructive Coronary Artery Disease Over 1‐Year Follow‐Up: Results From WISE‐CVD
por: Quesada, Odayme, et al.
Publicado: (2020)

Relationship between coronary function testing and migraine: results from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction project
por: Siak, Jessica, et al.
Publicado: (2021)

Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation)
por: Sedlak, Tara, et al.
Publicado: (2020)

Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women’s Ischemic Syndrome Evaluation study (WISE)
por: Jones, Erika, et al.
Publicado: (2020)

Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD)
por: Anderson, R. David, et al.
Publicado: (2019)

Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker
por: Pacheco, Christine, et al.
Publicado: (2021)

Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial
por: Birkeland, Kade, et al.
Publicado: (2017)

Typical angina is associated with greater coronary endothelial dysfunction but not abnormal vasodilatory reserve
por: AlBadri, Ahmed, et al.
Publicado: (2017)

Do women with statin-related myalgias have low vitamin D levels?
por: Minissian, Margo, et al.
Publicado: (2015)

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
por: Bairey Merz, C. Noel, et al.
Publicado: (2016)

SAT-LB99 Inflammation May Mediate Coronary Artery Disease in Women With Hypothalamic Hypoestrogenemia: Findings From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE)
por: Torbati, Tina, et al.
Publicado: (2020)

Left ventricular mass and myocardial scarring in women with hypertensive disorders of pregnancy
por: Quesada, Odayme, et al.
Publicado: (2020)

Renal Function and Coronary Microvascular Dysfunction in Women with Symptoms/Signs of Ischemia
por: Mohandas, Rajesh, et al.
Publicado: (2015)

Acetylcholine versus cold pressor testing for evaluation of coronary endothelial function
por: AlBadri, Ahmed, et al.
Publicado: (2017)

Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) Study
por: Aldiwani, Haider, et al.
Publicado: (2020)

Subclinical systolic and diastolic dysfunction in women with signs and symptoms of ischemia but no obstructive coronary disease: novel insights using myocardial feature tracking in the NHLBI WISE study
por: Nelson, Michael D, et al.
Publicado: (2016)

Comparison of fully quantitative and semi-quantitative measure of women's myocardial perfusion reserve for detection of microvascular coronary dysfunction
por: Chen, David, et al.
Publicado: (2013)

Depression Symptom Patterns as Predictors of Metabolic Syndrome and Cardiac Events in Symptomatic Women with Suspected Myocardial Ischemia: The Women’s Ischemia Syndrome Evaluation (WISE and WISE-CVD) Projects
por: Virzi, Nicole E., et al.
Publicado: (2022)

Five-year stroke rate in women with signs and symptoms of ischemia undergoing coronary angiography: a retrospective study from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)
por: Haftbaradaran, A, et al.
Publicado: (2015)

Reduced myocardial perfusion is common among subjects with ischemia and no obstructive coronary artery disease and heart failure with preserved ejection fraction: a report from the WISE-CVD continuation study
por: Aldiwani, Haider, et al.
Publicado: (2022)

Trans-myocardial omega-3 fatty acid gradient in coronary microvascular dysfunction
por: Keeley, Ellen C., et al.
Publicado: (2022)

Ultra-high sensitivity cardiac troponin-I concentration and left ventricular structure and function in women with ischemia and no obstructive coronary artery disease
por: Quesada, Odayme, et al.
Publicado: (2022)

Cold Pressor Stress Cardiac Magnetic Resonance Myocardial Flow Reserve Is Not Useful for Detection of Coronary Endothelial Dysfunction in Women with Signs and Symptoms of Ischemia and No Obstructive CAD
por: Landes, Sofy, et al.
Publicado: (2017)

TIMI Frame Count and Adverse Events in Women with No Obstructive Coronary Disease: A Pilot Study from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
por: Petersen, John W., et al.
Publicado: (2014)

Number and Function of Bone-Marrow Derived Angiogenic Cells and Coronary Flow Reserve in Women without Obstructive Coronary Artery Disease: A Substudy of the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
por: Mohandas, Rajesh, et al.
Publicado: (2013)

Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery Disease
por: Al-Badri, Ahmed, et al.
Publicado: (2018)

Case report: Repeat coronary function testing in women with ischemia and no obstructive coronary artery disease
por: Suppogu, Nissi, et al.
Publicado: (2023)

Oxidative Stress Is Associated With Diastolic Dysfunction in Women With Ischemia With No Obstructive Coronary Artery Disease
por: Raad, Mohamad, et al.
Publicado: (2020)

Interscan reproducibility of cardiovascular magnetic resonance myocardial perfusion reserve index in women with suspected coronary microvascular dysfunction and no obstructive coronary artery disease
por: AlBadri, Ahmed, et al.
Publicado: (2016)

Progression of coronary microvascular dysfunction to heart failure with preserved ejection fraction: a case report
por: Joung, Sandy, et al.
Publicado: (2019)

Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute‐Sponsored Women's Ischemia Syndrome Evaluation
por: Lee, Julie J., et al.
Publicado: (2019)

Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)
por: AlBadri, Ahmed, et al.
Publicado: (2017)

Symptom Presentation among Women with Suspected Ischemia and No Obstructive Coronary Artery Disease (INOCA)
por: Taha, Yasmeen K., et al.
Publicado: (2023)

Tissue characterization with native T1 mapping in suspected coronary microvascular dysfunction and no obstructive coronary artery disease: results from the NHLBI-sponsored WISE study
por: Shaw, Jaime L, et al.
Publicado: (2016)

Somatic Versus Cognitive Depressive Symptoms as Predictors of Coronary Artery Disease among Women with Suspected Ischemia: The Women’s Ischemia Syndrome Evaluation
por: Emami, Ashley S., et al.
Publicado: (2021)

Fitness attenuates long-term cardiovascular outcomes in women with ischemic heart disease and metabolic syndrome
por: Quesada, Odayme, et al.
Publicado: (2023)

Clinical Practice Variations in the Management of Ischemia With No Obstructive Coronary Artery Disease
por: Luu, Judy M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_guenh5agk0742ubde7jjs1sl4e